COVID-19 @ NIBIB

Share:

EmailFacebookLinkedInXWhatsAppShare

Covid-19 Banner

NIBIB's goal is to accelerate research, translation, and commercialization of technologies that will provide solutions to the COVID-19 pandemic.

NIBIB is administering the RADx® Tech and Advanced Technology Platforms (ATP) programs. These programs are part of the NIH RADx® Initiative to increase testing capacity and accessibility for SARS-CoV-2, the virus that causes COVID. In addition, NIBIB is supporting other technology development, imaging approaches, and digital platforms to address the pandemic.

Rapid Acceleration of Diagnostics (RADx®) Tech and ATP Programs

The RADx® Tech program is part of the NIH RADx® Initiative to increase testing capacity and accessibility for SARS-CoV-2, the virus that causes COVID. 

Summary data on proposals submitted to the RADx® Tech and ATP Programs.

The MakeMyTestCount.org website is an easy way to anonymously report test results for any brand of at-home COVID-19 test. This helps public health departments to assess needs and provide resources. Report your test results here

COVID-19 Research across NIBIB

Listing of COVID-19 related grants funded by NIBIB.

Learn how this collaborative network is using medical imaging and clinical data sciences to reveal unique features of COVID-19. Learn more about this resource.

Videos

View videos about RADx® Tech/ATP programs, interviews with the NIBIB Director and more.

Program Contacts

RADx® Tech/ATP programmatic or technical inquiries: info.radx@poctrn.org

All other RADx® Tech/ATP Applicants: RADxNIBIB@mail.nih.gov

SBIR/STTR Applicants: NIBIB-SBIR@mail.nih.gov

All others: COVID19NIBIB@nih.gov

Related News

December 6, 2023
program logo with text Home Test to Treat Program arranged to look like a house with a roof on top of the letter O in home
Home Test to Treat offers free testing, telehealth and treatment for both COVID-19 and for influenza A and B.

What:

The federal government has expanded the Home Test to Treat program, an entirely virtual community health program that offers free COVID-19 health services: at-home rapid tests, telehealth

October 19, 2023
Researchers at Ohio State University have developed nanocarriers derived from mice skin cells that reduced lung inflammation in mice. Further research could lead to a treatment for acute respiratory distress syndrome and other conditions.
October 16, 2023
Dendritic cells are key orchestrators of the immune response, but most vaccination strategies don’t effectively target them. NIBIB-funded researchers have developed biodegradable nanoparticles that are designed to deliver mRNA cargo to dendritic cells in the spleen. Combined with another type of immunotherapy, their vaccine had robust antitumor effects in multiple mouse models.
September 25, 2023
eMed is working with the National Institutes of Health to study what impact having more at-home tests will have in controlling spread of disease...NIH is funding the test kits and telehealth visits for 80,000 to 100,000 people who enroll in the study through June 2024. Source: Time
September 21, 2023
NIH will advance the development of home-based and point-of-care health technologies with awards to six technology research and development centers around the country. The centers comprise the Point of Care Technology Research Network (POCTRN) and will parlay the momentum of the original network established in 2007 by the NIBIB.